Home Psychedelic Stock Review Cybin (CLXPF CYBN) Gets $8.00 Price Target From H.C. Wainwright. Biotech NewsInstitutional Analyst NewsletterPsychedelic NewsPsychedelic Stock Review Cybin (CLXPF CYBN) Gets $8.00 Price Target From H.C. Wainwright. By Editor / Curator - July 26, 2021 Facebook Twitter Google+ Pinterest Linkedin Email Advancing Multiple Psychedelics in Multiple Indications; Initiating With a Buy and $8 Price Target. REPORT LIVE QUOTE INVESTOR DECK RELATED ARTICLESMORE FROM AUTHOR 2024 Watch List Nine Page Summary Report on GeoVax (GOVX) 2024 Watch List GeoVax (GOVX) Provides First Half 2024 Business Update. All News Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16. Biotech News FDA approves Amgen drug for tough-to-treat form of lung cancer. 2024 Watch List GeoVax Receives Massive $300+ Million BARDA Project NextGen Award! 2024 Watch List GeoVax (GOVX) Research Reports Archive Latest article Adding Quantum Pharmaceutical (QNTM) $4.10 to Reverse Split Stock Watch List. All News Editor / Curator - December 5, 2024 119% Gain Post Split Nine Page Summary Report on GeoVax (GOVX) 2024 Watch List Editor / Curator - August 19, 2024 This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier... GeoVax (GOVX) Provides First Half 2024 Business Update. 2024 Watch List Editor / Curator - July 9, 2024 Award of BARDA Project NextGen contract represents a significant milestone event; Total value...